323 related articles for article (PubMed ID: 37175882)
1. Intestinal Behcet's Disease: A Review of the Immune Mechanism and Present and Potential Biological Agents.
He K; Yan X; Wu D
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175882
[TBL] [Abstract][Full Text] [Related]
2. Intestinal Behçet's Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis?
Kim DH; Cheon JH
Yonsei Med J; 2016 Jan; 57(1):22-32. PubMed ID: 26632379
[TBL] [Abstract][Full Text] [Related]
3. Integrated Analysis of Microbiome and Metabolome Reveals Disease-Specific Profiles in Inflammatory Bowel Diseases and Intestinal Behçet's Disease.
Park Y; Ahn JB; Kim DH; Park IS; Son M; Kim JH; Ma HW; Kim SW; Cheon JH
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928402
[TBL] [Abstract][Full Text] [Related]
4. Update on the Treatment of Behcet's Disease of the Small Bowel with Biologic Agents.
Park Y; Cheon JH
Curr Gastroenterol Rep; 2020 Mar; 22(5):24. PubMed ID: 32193746
[TBL] [Abstract][Full Text] [Related]
5. Advances in Management of Intestinal Behçet's Disease: A Perspective From Gastroenterologists.
Cheon JH
J Rheum Dis; 2021 Jan; 28(1):4-16. PubMed ID: 37476392
[TBL] [Abstract][Full Text] [Related]
6. Updated treatment strategies for intestinal Behçet's disease.
Park YE; Cheon JH
Korean J Intern Med; 2018 Jan; 33(1):1-19. PubMed ID: 29207867
[TBL] [Abstract][Full Text] [Related]
7. [Intestinal manifestations of Behçet's disease].
Goloeva RG; Alekberova ZS; Lisitsyna TA; Stepanova EA; Orlova LP
Ter Arkh; 2019 May; 91(5):111-119. PubMed ID: 32598685
[TBL] [Abstract][Full Text] [Related]
8. Quality of life in Korean patients with inflammatory bowel diseases: ulcerative colitis, Crohn's disease and intestinal Behçet's disease.
Kim WH; Cho YS; Yoo HM; Park IS; Park EC; Lim JG
Int J Colorectal Dis; 1999 Feb; 14(1):52-7. PubMed ID: 10207731
[TBL] [Abstract][Full Text] [Related]
9. A case of intestinal Behcet's disease similar to Crohn's colitis.
Kim ES; Chung WC; Lee KM; Lee BI; Choi H; Han SW; Choi KY; Chung IS
J Korean Med Sci; 2007 Oct; 22(5):918-22. PubMed ID: 17982247
[TBL] [Abstract][Full Text] [Related]
10. [A survey of actual clinical application patterns in Korean diagnostic guidelines for inflammatory bowel disease].
Park SJ; Cheon JH; Ye BD; Choi CH; Kim YS; Kim YH; Kim JS; Jeen YT; Park YS; Han DS; Yang SK; Kim WH
Korean J Gastroenterol; 2012 Nov; 60(5):292-9. PubMed ID: 23172277
[TBL] [Abstract][Full Text] [Related]
11. Behçet's disease with intestinal involvement: case-based review.
Dzhus MB; Karasevska TA; Tsaralunga VM; Yurchenko AV; Ivashkivsky OI
Rheumatol Int; 2022 Sep; 42(9):1653-1660. PubMed ID: 35661907
[TBL] [Abstract][Full Text] [Related]
12. The treatment principles and targets for intestinal Behcet's disease.
He K; Wu D
Therap Adv Gastroenterol; 2023; 16():17562848231167283. PubMed ID: 37113192
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of a refractory intestinal Behcet's disease with an oncology history by Vedolizumab: a case report and literature review.
Li R; Li X; Zhou H; Shi Y; Wang F; Wu T; Liang J
Front Immunol; 2023; 14():1205046. PubMed ID: 37287984
[TBL] [Abstract][Full Text] [Related]
14. Anti-TNF-α agents for refractory intestinal Behçet's disease: case series and meta-analysis.
Zhan S; Liu C; Li N; Li T; Tian Z; Zhao M; Wu D; Chen M; Zeng Z; Zhuang X
Therap Adv Gastroenterol; 2022; 15():17562848221116666. PubMed ID: 36082178
[TBL] [Abstract][Full Text] [Related]
15. Anti-alpha-enolase antibody as a serologic marker and its correlation with disease severity in intestinal Behçet's disease.
Shin SJ; Kim BC; Kim TI; Lee SK; Lee KH; Kim WH
Dig Dis Sci; 2011 Mar; 56(3):812-8. PubMed ID: 20632102
[TBL] [Abstract][Full Text] [Related]
16. [Pathogenesis and treatment of intestinal Behçet's disease].
Lee CK; Kim HJ
Korean J Gastroenterol; 2007 Jul; 50(1):3-8. PubMed ID: 18172353
[TBL] [Abstract][Full Text] [Related]
17. Intestinal Behçet and Crohn's disease: two sides of the same coin.
Valenti S; Gallizzi R; De Vivo D; Romano C
Pediatr Rheumatol Online J; 2017 Apr; 15(1):33. PubMed ID: 28427473
[TBL] [Abstract][Full Text] [Related]
18. Differentiation between intestinal Behçet’s disease and Crohn’sdisease based on endoscopy.
Ye JF; Guan JL
Turk J Med Sci; 2019 Feb; 49(1):42-49. PubMed ID: 30761850
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors for Surgery in Patients with Intestinal Behçet's Disease During Anti-Tumor Necrosis Factor-Alpha Therapy.
Han SJ; Kang EA; Park J; Park SJ; Park JJ; Kim TI; Kim WH; Cheon JH
Yonsei Med J; 2023 Feb; 64(2):111-116. PubMed ID: 36719018
[TBL] [Abstract][Full Text] [Related]
20. The utility of apoptosis inhibitor of macrophages as a possible diagnostic marker in patients with Crohn's disease.
Ono Y; Kanmura S; Morinaga Y; Oda K; Kawabata K; Arima S; Sasaki F; Nasu Y; Tanoue S; Hashimoto S; Taguchi H; Uto H; Tsubouchi H; Ido A
BMC Gastroenterol; 2017 Mar; 17(1):40. PubMed ID: 28284201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
